Delivery Order SPE2DB24D2018-SPE2DB25FWWX5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 24, 2025, with an ultimate completion date of October 16, 2025. This is a firm fixed price, non-set-aside delivery order performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a $3,082.67 delivery order contract to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. The contract, which is not set-aside and operates under firm fixed pricing, is scheduled for completion by August 4, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector units, with an ultimate completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed at the contractor's corporate headquarters location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency awarded a $12,330.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injector supplies, with a completion date of October 3, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor for pharmaceutical products supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 15, 2025, valued at $12,330.68 for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price, non-set-aside delivery order with a completion deadline of September 8, 2025, and represents a child contract under AmerisourceBergen's larger federal contract vehicle with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injectors. This competitively awarded, non-set-aside contract was finalized on July 31, 2025, with an ultimate completion date of August 21, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract utilizes firm fixed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. The award was made on August 1, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $3,082.67 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of September 23, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Benlysta 200 mg/mL auto-injector with a ceiling value of $3,082.67. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with the company serving as the prime contractor on this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on September 9, 2025, with completion scheduled for September 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pediatric or adult immunosuppressant pharmaceutical delivery supporting military healthcare supply needs. The place of performance is AmerisourceBergen's corporate office located...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWWX5Delivery Order
The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. The contract was competitively awarded without set-aside designation and carries a completion date of October 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and military healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical devices. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract employs firm fixed pricing and reflects AmerisourceBergen Drug Corp's demonstrated capability to fulfill federal medical supply requirements through open competition with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/22/25 |